Opening Ceremony

08:00-08:15

Opening Remarks

Huey-Kang Sytwu

(Vice President, National Health Research Institutes, TW)

Miin-Fu Chen

(Superintendent Emeritus, Linkou Chang Gung Memorial Hospital, TW)

Yun Yen

(President Emeritus, Taipei Medical University, TW)

08:15-08:20

Welcome and Additional Remarks

Li-Tzong Chen

(National Health Research Institutes, TW)

Flavio G. Rocha

(Virginia Mason Medical Center, US)

08:20-08:30

Welcome and Introduction to CCF and ICRN

Stacie Lindsey

(Cholangiocarcinoma Foundation, US)

Milind Javle

(University of Texas MD Anderson Cancer Center, US)

Keynote Speech

Moderators: 　Jang-Yang Chang (National Cheng Kung University, TW)
Milind Javle (University of Texas MD Anderson Cancer Center, US)

08:30-09:00

Development of Effective Immune Checkpoint Cancer Therapy

Mien-Chie Hung

(China Medical University, TW)

Session 1　Epidemiology and Diagnosis

Session Chairs: Ming-Shiang Wu (National Taiwan University Hospital, TW)

Hsiu-Po Wang (National Taiwan University Hospital, TW)

09:00-09:20

Recent Adventure in Cholangiocarcinoma – Focus on Molecular Profiling

Yun Yen

(Taipei Medical University,TW)

09:20-09:40

Genetic and Environmental Risk Factors for Cholangiocarcinoma (CCA)

Tatsuhiro Shibata

(University of Tokyo, JP)

09:40-10:00

Biliary Imaging in Diagnosis and Staging

Bang-Bin Chen

(National Taiwan University Hospital, TW)

10:00-10:20

What is the Best Approach for Biopsy and Stenting Hilar Cholangiocarcinoma? (Sharing Experiences between East and West)

Jeffrey H. Lee

(University of Texas MD Anderson Cancer Center, US)

10:20-10:40

Wei-Chih Liao

(National Taiwan University Hospital, TW)

Session 2　Localized Disease: Surgery/Transplant

Session Chairs: Flavio G. Rocha (Virginia Mason Medical Center, US)

King-Teh Lee (Kaohsiung Medical University Hospital, TW)

Jingyu Cao (The Affiliated Hospital of QingDao University, CN)

10:50-11:10

Surgical Approach to Intrahepatic Cholangiocarcinoma

Shishir K.Maithel

(Emory University, US)

11:10-11:30

Surgical Approach to Hilar Cholangiocarcinoma

Michael A. Choti

(Banner MD Anderson Cancer Center, US)

11:30-11:50

Hepatopancreaticoduodenectomy (HPD) for Cholangiocarcinoma

Masato Nagino

(Nagoya University, JP)

11:50-12:10

Liver Transplantation for Cholangiocarcinoma

Keri E. Lunsford

(Houston Methodist Hospital, US)

12:10-12:20

Open Discussion

Session 3A　Medical Oncology/Advanced Disease Tumor Board

Session chairs: Li-Tzong Chen (National Health Research Institutes, TW)

Mitesh Borad (Mayo Clinic, US)

Tianqiang Song (Tianjin Medical University Cancer Institute and Hospital, CN)

13:20-13:40

The Role of Adjuvant Therapy in Biliary Tract Tumors

John N. Primrose

(University of Southampton, UK)

13:40-14:00

The Future Potential of Immunotherapy in Biliary Tract Cancer

Nilofer S. Azad

(Johns Hopkins University, US)

14:00-14:20

Precision Medicine on the Horizon for Cholangiocarcinoma

Lipika Goyal

(Massachusetts General Hospital Cancer Center, US)

14:20-14:40

Open Discussion

Session 3B　Parallel Nursing Session (R803)

Session chairs: Susan Acquisto (Cholangiocarcinoma Foundation, US)

Sui-Whi Jane (Chang Gung University of Science and Technology, TW)

13:20-13:35

An International Collaborative of Clinical
Nursing Practice Evidence Based
Guidelines for Care of Patients with
Cholangiocarcinoma

Susan Acquisto

(Cholangiocarcinoma Foundation, US)

13:35-13:50

Cholangitis: Nursing Assessment and Management

Wen-Tzu Chiu

(National Taiwan University Hospital, TW)

13:50-14:05

Guidelines for Care of the Patient Receiving Chemotherapy

Renuka V. Iyer

(Roswell Park Cancer Institute, US)

14:05-14:20

Complications of Radiation Therapy: Key Concepts for Patient Education

Lorraine Drapek

(Massachusetts General Hospital, US)

14:20-14:35

Living Well with Cancer – A Personalized and Need-based Cancer Care

Yeur-Hur Lai

(National Taiwan University, TW)

14:35-14:50

Nutrition Care in Patients with Cancer

Pei-Hung Chang

(Keelung Chang Gung Memorial Hospital, TW)

14:50-15:00

Open Discussion

Session 4　Parallel Multidiscipline Approach for Locally Advanced Diseases

Session Chairs: Rheun-Chuan Lee (Taipei Veterans General Hospital, TW)

Virote Sriuranpong (Chulalongkorn University, TH)

Jaw-Town Lin (China Medical University Hospital, TW)

15:00-15:20

Intra-hepatic Cholangiocarcinoma: How to Choose Among Different Loco-regional Therapies?

Bruno C. Odisio

(University of Texas MD Anderson Cancer Center, US)

15:20-15:40

Role of Radiotherapy in Cholangiocarcinoma

Jinsil Seong

(YonSei University, KR)

15:40-16:00

Down-staging Locally Advanced Disease

Rachna T. Shroff

(University of Arizona Cancer Center, US)

16:00-16:20

Percutaneous Transhepatic Portal Vein Embolization and Evaluation of Future Liver Remnant

Ta-Sen Yeh

(Linkou Chang Gung Memorial Hospital, TW)

16:20-17:50

Questionnaire and Debates (Treatment Strategies in Locally Advanced CCA)

Moderators:

Eugene J. Koay

(University of Texas MD Anderson Cancer Center, US)

Chiun Hsu

(National Taiwan University Hospital, TW)

Stephen L. Chan

(The Chinese University of Hong Kong, HK)

Closing

17:50-18:00

Day 1 Session Closing Remarks

Li-Tzong Chen

(National Health Research Institutes, TW)

Session 5A　Meet the Expert

Session chair: Li-Tzong Chen (National Health Research Institutes, TW)

08:15-08:30

Immune Biomarkers of
Cholangiocarcinoma: MSI and EBV (MSD)

Ming-Huang Chen

(Taipei Veterans General Hospital, TW)

08:30-08:45

The Role of TS-1 in Cholangiocarcinoma
(TTY)

Nai-Jung Chiang

(National Health Research Institutes, TW)

Session 6　What’s New in Cholangiocarcinoma Research

Session Chairs: Junji Furuse (Kyorin University, JP)

Lipika Goyal (Massachusetts General Hospital Cancer Center, US)

09:00-09:20

Biomarkers in Cholangiocarcinoma

Chien-Feng Li

(Chi Mei Medical Center, TW)

09:20-09:40

Drugs and Targets in Development

Ming-Huang Chen

(Taipei Veterans General Hospital, TW)

09:40-10:00

Clinical Trials Incorporating Translational
Targets

Takuji Okusaka

(National Cancer Center Hospital, JP)

10:00-10:20

Liver-directed Therapy for Cholangiocarcinoma

Sean P. Cleary

(Mayo Clinic, US)

10:20-10:30

Open Discussion

Session 7　Collaborations and Partnerships

Session Chairs: John Bridgewater (University College London Cancer Institute, UK)

Yan-Shen Shan (National Cheng Kung University Hospital, TW)

10:30-10:45

How to Use Large Databases in Research

Chun-Ying Wu

(Taipei Veterans General Hospital, TW)

10:45-11:00

Consolidating the Treatment Guidelines of Chemotherapy for Cholangiocarcinoma between the East and West

Junji Furuse

(Kyorin University, JP)

11:00-11:15

The Patient and Caregiver Perspective

Patricia Maxin

(Cholangiocarcinoma Foundation, US)

11:15-11:30

Collaborating with Patient Advocacy
Groups

Stacie Lindsey

(Cholangiocarcinoma Foundation, US)

11:30-11:45

Introduction of Taiwan Liver Cancer
Network

Shiu-Feng Huang

(National Health Research Institutes, TW)

11:45-11:55

Open Discussion

Closing Remarks

11:55-12:20

Closing Remarks

Li-Tzong Chen

(National Health Research Institutes, TW)

Flavio G. Rocha

(Virginia Mason Medical Center, US)